3.80
Precedente Chiudi:
$4.09
Aprire:
$4.17
Volume 24 ore:
1.67M
Relative Volume:
1.75
Capitalizzazione di mercato:
$216.35M
Reddito:
-
Utile/perdita netta:
$-82.44M
Rapporto P/E:
-2.0213
EPS:
-1.88
Flusso di cassa netto:
$-66.75M
1 W Prestazione:
-3.06%
1M Prestazione:
+16.92%
6M Prestazione:
+173.38%
1 anno Prestazione:
+14.11%
Black Diamond Therapeutics Inc Stock (BDTX) Company Profile
Nome
Black Diamond Therapeutics Inc
Settore
Industria
Telefono
617-417-5868
Indirizzo
ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA
Confronta BDTX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
BDTX
Black Diamond Therapeutics Inc
|
3.80 | 232.87M | 0 | -82.44M | -66.75M | -1.88 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-09-04 | Iniziato | Guggenheim | Buy |
2025-07-01 | Ripresa | Raymond James | Outperform |
2024-07-31 | Iniziato | Raymond James | Outperform |
2023-07-14 | Iniziato | Piper Sandler | Overweight |
2023-06-30 | Aggiornamento | Stifel | Hold → Buy |
2023-06-28 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
2023-06-27 | Aggiornamento | Wedbush | Neutral → Outperform |
2022-03-29 | Downgrade | Wedbush | Outperform → Neutral |
2022-03-22 | Downgrade | H.C. Wainwright | Buy → Neutral |
2021-09-30 | Iniziato | Stifel | Hold |
2021-01-07 | Iniziato | Wedbush | Outperform |
2020-11-24 | Iniziato | Berenberg | Buy |
2020-05-04 | Iniziato | H.C. Wainwright | Buy |
2020-02-24 | Iniziato | Canaccord Genuity | Buy |
2020-02-24 | Iniziato | Cowen | Outperform |
2020-02-24 | Iniziato | JP Morgan | Overweight |
2020-02-24 | Iniziato | Jefferies | Buy |
Mostra tutto
Black Diamond Therapeutics Inc Borsa (BDTX) Ultime notizie
How geopolitical tensions affect Black Diamond Therapeutics Inc. stockStop Loss & High Conviction Investment Ideas - newser.com
Using RSI to spot recovery in Black Diamond Therapeutics Inc.Jobs Report & Community Consensus Trade Signals - newser.com
Why Black Diamond Therapeutics Inc. is moving todayTrade Performance Summary & Verified Swing Trading Watchlists - newser.com
Black Diamond Therapeutics (BDTX): Valuation Insights After Surging Interest From Strong Earnings and Growth Momentum - Yahoo Finance
Black Diamond Therapeutics Inc Stock Analysis and ForecastPrice Momentum Alerts & Get Peace of Mind with Portfolio Health Checks - earlytimes.in
4 Biotechnology Stocks Lead Momentum Gains Amid Strong Technicals - Benzinga
Applying Elliott Wave Theory to Black Diamond Therapeutics Inc.2025 Trading Volume Trends & Safe Entry Trade Reports - newser.com
Black Diamond Therapeutics' (BDTX) Sell (D) Rating Reaffirmed at Weiss Ratings - MarketBeat
Black Diamond Therapeutics Hits New 52-Week High of $4.11 - Markets Mojo
Black Diamond Therapeutics Hits New 52-Week High at $3.90 - Markets Mojo
BDTX Stock Hits 52 Week High: Is There More Room for Growth? - sharewise.com
How to use Fibonacci retracement on Black Diamond Therapeutics Inc.2025 Risk Factors & AI Based Buy and Sell Signals - newser.com
How to escape a deep drawdown in Black Diamond Therapeutics Inc.2025 Market Overview & Risk Managed Trade Strategies - newser.com
Will Black Diamond Therapeutics Inc. stock recover faster than market2025 Geopolitical Influence & Consistent Profit Trading Strategies - newser.com
Using Bollinger Bands to evaluate Black Diamond Therapeutics Inc.July 2025 Highlights & Free Long-Term Investment Growth Plans - newser.com
Black Diamond Therapeutics, Inc. (BDTX) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Black Diamond Therapeutics Hits New 52-Week High at $4.03 - Markets Mojo
Will Black Diamond Therapeutics Inc. stock benefit from infrastructure spendingQuarterly Earnings Summary & Community Supported Trade Ideas - newser.com
Published on: 2025-10-05 06:35:20 - newser.com
Technical signs of recovery in Black Diamond Therapeutics Inc.July 2025 Closing Moves & Smart Swing Trading Alerts - newser.com
Published on: 2025-10-03 07:14:35 - newser.com
Why analysts upgrade Black Diamond Therapeutics Inc. stockMarket Growth Summary & Community Consensus Picks - newser.com
Smart tools for monitoring Black Diamond Therapeutics Inc.’s price actionWeekly Volume Report & Daily Profit Focused Screening - newser.com
Published on: 2025-10-03 00:58:16 - newser.com
Published on: 2025-10-02 23:04:01 - newser.com
Visual trend scoring systems applied to Black Diamond Therapeutics Inc.July 2025 Sentiment & Detailed Earnings Play Strategies - newser.com
Black Diamond Therapeutics (BDTX) Has a New Rating from Freedom Capital Markets - The Globe and Mail
Published on: 2025-10-01 08:07:11 - newser.com
Regression analysis insights on Black Diamond Therapeutics Inc. performance2025 Support & Resistance & Stock Market Timing Techniques - newser.com
Black Diamond Therapeutics stock initiated with Buy rating at Freedom Capital - Investing.com Canada
Promising Penny Stocks To Watch In September 2025 - Yahoo Finance
Black Diamond Therapeutics Inc Azioni (BDTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):